Effects of inhaled dry powder ipratropium bromide on recovery from exercise of horses with COPD.

The research evaluates the effect of ipratropium bromide, a bronchodilator, on recovery factors in horses with chronic obstructive pulmonary disease (COPD) after rigorous exercise. The results showed that the inhalant improves only one parameter, alveolar oxygen tension, and has minimal impact on other respiratory or cardiac parameters during the recovery phase.

Research Design

• The research focused on studying six saddle horses suffering from chronic obstructive pulmonary disease (COPD). They were picked after displaying airway obstruction, a common symptom of COPD. The horses inhaled either a placebo or ipratropium (2400 microg/horse) before exercise.
• Pulmonary function tests were conducted 15 minutes post-inhalation. Horses then underwent strenuous treadmill exercise, after which they had a 10-minute recovery walk.
• During the first and last minute of the recovery walk, several parameters such as respiratory flow, oxygen and carbon dioxide levels in the respired gas, changes in pleural pressure, and heart rate were documented.
• Arterial and mixed venous blood samples were taken to assess gas tensions, haemoglobin, and plasma lactate concentrations. Other parameters measured include oxygen consumption, carbon dioxide production, tidal volume, alveolar oxygen tension, alveolar ventilation, the difference in oxygen between alveolar space and pulmonary capillaries, and total pulmonary resistance.

Results and Observations

• The study showed that the only significant improvement in horses after consuming ipratropium was the increased alveolar oxygen tension (PAO2). However, this improvement was not accompanied by noticeable improvements in other ventilatory or cardiorespiratory parameters.
• Further, it was noted that while ipratropium acted as an effective bronchodilator at rest, its effect on airway calibre during the recovery period was minimal.
• The study suggested that the short-term recovery period was influenced by adjustments induced by exercise, which might overshadow the bronchodilatory effects of inhaled ipratropium observed before exercise.

Conclusions

• The study indicated that the effect of ipratropium as a bronchodilator among COPD-affected horses is limited, with a significant positive impact observed only on alveolar oxygen tension (PAO2).
• The bronchodilatory effect of ipratropium was found to be less impactful during the recovery period post-exercise, meaning the bronchial dilation led by exercise itself may override the effects of ipratropium.